Evidence map›Paper›PMID 22876297›Full record

ArticlePloS one2012

Aromatase inhibition attenuates desflurane-induced preconditioning against acute myocardial infarction in male mouse heart in vivo.

Virginija Jazbutyte, Jan Stumpner, Andreas Redel, Johan M Lorenzen, Norbert Roewer, Thomas Thum, Franz Kehl

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Aromatase enzyme: Paving the way for exploring aromatization for cardio-renal protection.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mechanisms and implications of sex differences in cardiac aging.The journal of cardiovascular aging · 2022
    Article
  8. Review
  9. Cardiovascular Risks Associated with Gender and Aging.Journal of cardiovascular development and disease · 2019
    Review
  10. Brain aromatase modulates cardiac functions in embryonic zebrafish.International journal of veterinary science and medicine · 2019
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Estrogens in Male Physiology.Physiological reviews · 2017
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Virginija JazbutyteInstitute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, MHH, Hannover, Germany. vjazbutyte@hotmail.com
Jan Stumpner
Andreas Redel
Johan M Lorenzen
Norbert Roewer
Thomas Thum
Franz Kehl
Medizinische Hochschule Hannover · DEUniversity of Würzburg · DEStädtisches Klinikum Karlsruhe · DEUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The volatile anesthetic desflurane (DES) effectively reduces cardiac infarct size following experimental ischemia/reperfusion injury in the mouse heart. We hypothesized that endogenous estrogens play a role as mediators of desflurane-induced preconditioning against myocardial infarction. In this study, we tested the hypothesis that desflurane effects local estrogen synthesis by modulating enzyme aromatase expression and activity in the mouse heart. Aromatase metabolizes testosterone to 17β- estradiol (E2) and thereby significantly contributes to local estrogen synthesis. We tested aromatase effects in acute myocardial infarction model in male mice. The animals were randomized and subjected to four groups which were pre-treated with the selective aromatase inhibitor anastrozole (A group) and DES alone (DES group) or in combination (A+DES group) for 15 minutes prior to surgical intervention whereas the control group received 0.9% NaCl (CON group). All animals were subjected to 45 minutes ischemia following 180 minutes reperfusion. Anastrozole blocked DES induced preconditioning and increased infarct size compared to DES alone (37.94 ± 15.5% vs. 17.1 ± 3.62%) without affecting area at risk and systemic hemodynamic parameters following ischemia/reperfusion. Protein localization studies revealed that aromatase was abundant in the murine cardiovascular system with the highest expression levels in endothelial and smooth muscle cells. Desflurane application at pharmacological concentrations efficiently upregulated aromatase expression in vivo and in vitro. We conclude that desflurane efficiently regulates aromatase expression and activity which might lead to increased local estrogen synthesis and thus preserve cellular integrity and reduce cardiac damage in an acute myocardial infarction model.

Indexed as

Ischemic Preconditioning, MyocardialAnesthetics, InhalationAnimalsAromataseAromatase InhibitorsDesfluraneGene Expression RegulationHemodynamicsHumansHuman Umbilical Vein Endothelial CellsIsofluraneMaleMiceMice, Inbred C57BLMyocardial InfarctionMyocytes, Smooth MuscleAnesthetics, InhalationAromataseAromatase InhibitorsDesfluraneIsoflurane

Identifiers

PMID22876297
PMCPMC3410886
OpenAlexW2068404378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.